Skip to main content
KYONGBO PHARMACEUTICAL CO., LTD. logo

KYONGBO PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 214390 ISIN · KR7214390007 LEI · 988400YKOM1CHDS6R917 KO Manufacturing
Filings indexed 206 across all filing types
Latest filing 2024-04-01 Legal Proceedings Report
Country KR South Korea
Listing KO 214390

About KYONGBO PHARMACEUTICAL CO., LTD.

https://www.kbpharma.co.kr/en/home

Kyongbo Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished drug products. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering integrated services from early-stage development through to commercial cGMP production. Its core product portfolio includes a diverse range of APIs, such as sterile and non-sterile cephalosporins, carbapenem antibiotics, and high-potency cytotoxic anti-cancer agents. In addition to APIs, the company manufactures finished dosage forms, including solid oral medications and sterile injectables. Kyongbo Pharmaceutical utilizes dedicated and segregated manufacturing facilities to produce its specialized product lines, supported by a strong commitment to research and innovation in API synthesis.

Recent filings

Filing Released Lang Actions
조회공시요구(풍문또는보도)에대한답변(미확정)
Legal Proceedings Report Classification · 100% confidence The document is a response to a regulatory inquiry (Korea Exchange) regarding rumors of embezzlement by a company executive. It details the status of legal proceedings and investigations. Since it pertains to legal matters and regulatory compliance regarding potential criminal activity, it fits best under the 'Legal Proceedings Report' category.
2024-04-01 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Legal Proceedings Report Classification · 100% confidence The document is a response to a regulatory inquiry (Korea Exchange) regarding rumors or reports of embezzlement by an executive. It is a formal regulatory announcement concerning legal/compliance matters and does not fit into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a general regulatory filing.
2024-03-28 Korean
매매거래정지및정지해제(풍문등조회공시)
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice regarding the suspension of trading for Kyongbo Pharmaceutical due to rumors of embezzlement by an executive. It is a specific regulatory announcement issued to the exchange, which does not fit into financial reporting or corporate action categories, making it a standard regulatory filing.
2024-03-27 Korean
조회공시요구(풍문또는보도)
Legal Proceedings Report Classification · 100% confidence The document is a formal request from a regulatory body (exchange) to a company (Kyungbo Pharmaceutical) to clarify rumors or media reports regarding alleged embezzlement by an executive. This is a standard regulatory disclosure requirement for listed companies, which does not fit into specific categories like financial reports or M&A, making it a regulatory filing.
2024-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of an Annual General Meeting (AGM) for the company 'Kyungbo Pharmaceutical'. It details the outcomes of shareholder votes on financial statements, dividend declarations, board appointments, and other agenda items. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides the official record of the decisions made during the general meeting.
2024-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of a new outside director (Yoo Tae-hyun) for Kyungbo Pharmaceutical. This falls under the category of changes to the board of directors.
2024-03-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.